Botanical

Chamomile

Also called German chamomile, Matricaria chamomilla, Matricaria recutita

By Kymata Labs EditorialMedical review pendingLast reviewed October 11, 2026 · What changed

Kymata Health may earn a commission from links on separate product pages. This page contains no product links. Educational reference, not medical advice.

Summary

Chamomile extract has been tested for generalised anxiety. An 8-week trial in 57 people found greater symptom reduction than placebo, and a long-term trial kept symptoms lower but did not significantly reduce relapse. Pooled sleep studies report better sleep-quality scores. Allergic reactions, including anaphylaxis, are possible with daisy-family allergies.

Top graded outcomes:C evidence grade Generalised anxiety disorder symptomsC evidence grade Sleep qualityD evidence grade Relapse of generalised anxiety disorder

Key facts

Anxiety (GAD)
Greater Hamilton Anxiety score reduction than placebo in an 8-week trial of 57 people[2]
Long-term use
Continuing 1,500 mg/day kept symptoms lower over 26 weeks; relapse was not significantly reduced[3]
Sleep
Pittsburgh Sleep Quality Index scores improved in pooled studies; sleep duration and daytime function did not[4]
Interactions
Interactions with warfarin and some liver-metabolised drugs have been reported[1]
Evidence base
3 graded human outcomes on this page
Last reviewed
October 11, 2026

How it works

ProposedThe trial extract was standardised to apigenin, a chamomile flavonoid that binds benzodiazepine sites linked to GABA-A receptors in laboratory studies; its role in people is unproven.[2]

What the human research says

Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.

At a glance: strongest evidence per outcome

Evidence at a glance: strongest human evidence per outcome
OutcomeGradeEffectStrongest evidenceRows
SleepGrade CImprovedSystematic review of 10 trials · n = 772 · 2024Form tested: Chamomile extract or tea1 row
AnxietyGrade CImprovedRCT · n = 57 · 2009Form tested: Pharmaceutical-grade German chamomile extract, 220 mg capsules2 rowsIncludes this form

Every graded row

Outcome
Grade
Form tested
Sort

Showing 3 of 3 outcomes. Human trials only.

OutcomeEffectGradeBest evidencePMID
Sleep qualityImprovedGrade C

Systematic review · n = 772 · 2024

Healthy and diseased adults in 10 studies (PSQI pooled from 5)

Form: Chamomile extract or tea · Dose: Varied across trials · Duration: Varied across trials

Pittsburgh Sleep Quality Index improved by 1.88 points; sleep duration, efficiency and daytime functioning did not improve.

39106912 (opens PubMed)Source [4]
Generalised anxiety disorder symptomsImprovedGrade C

RCT · n = 57 · 2009

Outpatients with mild to moderate generalised anxiety disorder

Form: Pharmaceutical-grade German chamomile extract, 220 mg capsules · Dose: 220–1,100 mg/day (1–5 capsules, titrated) · Duration: 8 weeks

Total Hamilton Anxiety score fell more than with placebo (p=0.047); secondary measures moved the same way; adverse events were similar.

19593179 (opens PubMed)Source [2]
Relapse of generalised anxiety disorderMixedGrade D

RCT · n = 93 · 2016

Responders after 12 weeks of open-label chamomile in moderate to severe generalised anxiety disorder (179 enrolled)

Form: Pharmaceutical-grade chamomile extract · Dose: 500 mg three times daily (1,500 mg/day) · Duration: 12-week open-label phase, then 26 weeks randomised

Relapse was 15.2% with continued chamomile vs 25.5% after switching to placebo (HR 0.52, not significant); anxiety symptoms stayed significantly lower with chamomile.

27912875 (opens PubMed)Source [3]

Forms

FormElemental %Absorption (human data)GI toleranceStudied for
Standardised chamomile extract capsulesVariesNot applicable (whole compound or extract; no elemental fraction)No head-to-head human absorption data in the sources cited here.Side effects were uncommon and similar to placebo in the anxiety trials.[2][3]Anxiety trials
Chamomile teaVariesNot applicable (whole compound or extract; no elemental fraction)No head-to-head human absorption data in the sources cited here.Likely safe in food amounts; allergic reactions can occur.[1]Some sleep studies

Studied doses

Doses studied in human trials ranged from 220 mg/day, titrated up to 1,100 mg/day over 8 weeks, to 500 mg three times daily (1,500 mg/day) for a 12-week open-label phase followed by 26 randomised weeks.[2][3]

These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Interactions

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

Medicines

  • Warfarin and drugs metabolised by the liverNIH fact sheetNCCIH reports interactions with warfarin and some liver-metabolised drugs, and theoretical interactions with sedatives.[1]

Who should be careful

Daisy-family allergies
Allergic reactions, including severe hypersensitivity and anaphylaxis, are more likely with allergies to ragweed, chrysanthemums, marigolds or daisies.[1]
People on warfarin or sedatives
Reported or theoretical interactions; check with the prescriber.[1]

Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

Frequently asked questions

Does chamomile help anxiety?

One 8-week trial in mild to moderate generalised anxiety found a modest benefit over placebo; a long-term trial kept symptoms lower but did not significantly cut relapse.[2][3]

Does chamomile help sleep?

Pooled studies found better sleep-quality scores but no longer sleep or better daytime function.[4]

What dose was studied?

Extract capsules from 220 mg up to 1,500 mg a day; tea strengths were not standardised.[2][3]

Who should avoid chamomile?

People allergic to ragweed or other daisy-family plants, and anyone on warfarin without checking first.[1]

Sources

  1. [1]Chamomile. National Center for Complementary and Integrative Health (NCCIH), 2024. fact-sheet
  2. [2]A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.. J Clin Psychopharmacol, 2009. RCT PMID 19593179
  3. [3]Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.. Phytomedicine, 2016. RCT PMID 27912875
  4. [4]Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials.. Complement Ther Med, 2024. systematic-review PMID 39106912

What changed

  1. October 11, 2026 · all · new page (encyclopedia expansion, A–L)First draft. Every PMID checked against NCBI E-utilities (title, journal and year taken from the PubMed record) and each evidence row written from its PubMed abstract; self-reviewed in a separate adversarial pass.Writer: Kymata Labs Editorial · No credentialed reviewer yet

How we write, grade and correct these pages: editorial and evidence policy.

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Supplements and vitamins: every page →Supplement & Nutrient Encyclopedia →Browse all topics →

Evidence-graded supplement stacks →